{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T04:49:56Z","timestamp":1792039796759,"version":"4.4.0"},"reference-count":16,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T00:00:00Z","timestamp":1779321600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T00:00:00Z","timestamp":1779321600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Med Chem Res"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1007\/s00044-026-03575-w","type":"journal-article","created":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T04:14:11Z","timestamp":1779336851000},"page":"2045-2054","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["MRS2339, a cardiac P2X4 receptor nucleotide activator, improves systolic function in heart failure"],"prefix":"10.1007","volume":"35","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4162-582X","authenticated-orcid":false,"given":"Ronghua","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunxia","family":"Cronin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2943-1245","authenticated-orcid":false,"given":"Khaled","family":"Qanud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T. Santhosh","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Hintze","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4189-8465","authenticated-orcid":false,"given":"Fabio A.","family":"Recchia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7329-7488","authenticated-orcid":false,"given":"Stanko S.","family":"Stojilkovic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5297-3694","authenticated-orcid":false,"given":"Claudio","family":"Coddou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8104-1493","authenticated-orcid":false,"given":"Kenneth A.","family":"Jacobson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruce T.","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,21]]},"reference":[{"key":"3575_CR1","doi-asserted-by":"publisher","first-page":"e895","DOI":"10.1161\/CIR.0000000000001063","volume":"145","author":"PA Heidenreich","year":"2022","unstructured":"Heidenreich PA, Bozkurt B, Aguilar D, Allen LA, Byunt JJ, Colvin MM, Deswal A, Drazner MH, Dunlay SM, Evers LR, Fang JC, Fedson SE, Fonarow GC, Hayek SS, Hernandez AF, Khazanie P, Kittleson MM, Lee CS, Link MS, Milano CA, Nnacheta LC, Sandhu AT, Warner Stevenson L, Vardeny O, Vest AR, Yancy CW. 2022 AHA\/ACC\/HFSA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation. 2022;145:e895\u20131032. https:\/\/doi.org\/10.1161\/CIR.0000000000001063. https:\/\/www.ahajournals.","journal-title":"Circulation"},{"issue":"7","key":"3575_CR2","doi-asserted-by":"publisher","first-page":"650658","DOI":"10.1001\/jamacardio.2018.0522","volume":"3","author":"LW Miller","year":"2018","unstructured":"Miller LW, Rogers JG. Evolution of Left Ventricular Assist Device Therapy for Advanced Heart Failure. JAMA Cardiol. 2018;3(7):650658. https:\/\/jamanetwork.com\/journals\/jamacardiology\/article-abstract\/2678664.","journal-title":"JAMA Cardiol"},{"key":"3575_CR3","doi-asserted-by":"publisher","first-page":"1209","DOI":"10.1016\/j.jacc.2012.08.1029","volume":"61","author":"LW Miller","year":"2013","unstructured":"Miller LW, Guglin M. Patient Selection for Ventricular Assist Devices. J Am Coll Cardiol. 2013;61:1209\u201321. https:\/\/doi.org\/10.1016\/j.jacc.2012.08.1029.","journal-title":"J Am Coll Cardiol"},{"key":"3575_CR4","doi-asserted-by":"publisher","first-page":"2841","DOI":"10.1161\/CIRCULATIONAHA.118.035566","volume":"138","author":"JJ Han","year":"2018","unstructured":"Han JJ, Acker MA, Atluri P. Left Ventricular Assist Devices. Synergistic Model Between Technology and Medicine. Circulation. 2018;138:2841\u201351. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.118.035566. https:\/\/www.ahajournals.org\/doi\/.","journal-title":"Circulation"},{"key":"3575_CR5","doi-asserted-by":"publisher","first-page":"1077","DOI":"10.1152\/ajpheart.00515.2006","volume":"292","author":"JB Shen","year":"2007","unstructured":"Shen JB, Cronin C, Sonin D, Joshi BV, Nieto M, Harrison D, Jacobson KA, Liang BT. P2X purinergic receptor-mediated ionic current in cardiac myocytes of calsequestrin model of cardiomyopathy. Implications for the treatment of heart failure. Am J Physiol Heart Circ Physiolo. 2007;292:1077\u201384. https:\/\/doi.org\/10.1152\/ajpheart.00515.2006.","journal-title":"Am J Physiol Heart Circ Physiolo"},{"key":"3575_CR6","doi-asserted-by":"publisher","first-page":"661","DOI":"10.3389\/fphar.2017.00661","volume":"8","author":"G Burnstock","year":"2017","unstructured":"Burnstock G. Purinergic signaling: Therapeutic developments. Front Pharmacol. 2017;8:661. https:\/\/doi.org\/10.3389\/fphar.2017.00661.","journal-title":"Front Pharmacol"},{"key":"3575_CR7","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1096\/fj.05-4749com","volume":"20","author":"JB Shen","year":"2006","unstructured":"Shen JB, Pappano AJ, Liang BT. Extracellular ATP-stimulated current in wild-type and P2X4 receptor transgenic mouse ventricular myocytes: implications for a cardiac physiologic role of P2X4 receptors. FASEB J. 2006;20:277\u201384. https:\/\/doi.org\/10.1096\/fj.05-4749com. https:\/\/faseb.onlinelibrary.wiley.com\/doi\/.","journal-title":"FASEB J"},{"key":"3575_CR8","doi-asserted-by":"publisher","first-page":"920","DOI":"10.1124\/jpet.109.164376","volume":"333","author":"SY Zhou","year":"2010","unstructured":"Zhou SY, Mamdani M, Qanud K, Shen JB, Pappano A, Kumar TS, Jacobson KA, Hintze T, Recchia FA, Liang BT. Treatment of heart failure by a methanocarba derivative of adenosine monophosphate. Implication for a role of cardiac P2X purinergic receptors. J Pharm Exp Th. 2010;333:920\u20138. https:\/\/jpet.aspetjournals.org\/action\/showPdf?pii=S0022-3565%2824%2945819-9.","journal-title":"J Pharm Exp Th"},{"key":"3575_CR9","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1161\/CIRCHEARTFAILURE.113.001023","volume":"7","author":"T Yang","year":"2014","unstructured":"Yang T, Shen JB, Yang R, Redden J, Dodge-Kafka K, Grady J, Jacobson KA, Liang BT. Novel cardioprotective role of endogenous cardiac myocyte P2X4 receptors in heart failure. Circ Heart Fail. 2014;7:510\u20138. https:\/\/doi.org\/10.1161\/CIRCHEARTFAILURE.113.001023. https:\/\/www.ahajournals.org\/doi\/.","journal-title":"Circ Heart Fail"},{"key":"3575_CR10","doi-asserted-by":"publisher","first-page":"2090","DOI":"10.1021\/jm010538v","volume":"45","author":"RG Ravi","year":"2002","unstructured":"Ravi RG, Kim HS, Servos J, Zimmermann H, Lee K, Maddileti S, Boyer JL, Harden TK, Jacobson KA. Adenine nucleotides analogues locked in a Northern methanocarba conformation: Enhanced stability and potency as P2Y1 receptor agonists. J Med Chem. 2002;45:2090\u2013100. https:\/\/doi.org\/10.1021\/jm010538v.","journal-title":"J Med Chem"},{"key":"3575_CR11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.csbj.2014.11.002","volume":"13","author":"R Yang","year":"2015","unstructured":"Yang R, Beqiri D, Shen JB, Redden J, Dodge-Kafka K, Jacobson KA, Liang BT. P2X4 Receptor-eNOS Signaling Pathway in Cardiac Myocytes as a Novel Protective Mechanism in Heart Failure. Comput Struct Biotechnol J. 2015;13:1\u20137. https:\/\/doi.org\/10.1016\/j.csbj.2014.11.002.","journal-title":"Comput Struct Biotechnol J"},{"key":"3575_CR12","doi-asserted-by":"publisher","first-page":"28470","DOI":"10.1074\/jbc.273.43.28470","volume":"273","author":"Y Sato","year":"1998","unstructured":"Sato Y, Ferguson DG, Sako H, Dorn GW II, Kadambi VJ, Yatani A, Hoit BD, Walsh RA, Kranias EG. Cardiac-specific overexpression of mouse cardiac calsequestrin is associated with depressed cardiovascular function and hypertrophy in transgenic mice. J Biol Chem. 1998;273:28470\u20137. https:\/\/www.jbc.org\/action\/showPdf?pii=S0021-9258%2819%2959619-3.","journal-title":"J Biol Chem"},{"key":"3575_CR13","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1007\/s11302-020-09688-0","volume":"16","author":"JB Shen","year":"2020","unstructured":"Shen JB, Toti KS, Chakraborty S, Kumar TS, Cronin C, Liang BT, Jacobson KA. Prevention and rescue of cardiac dysfunction by methanocarba adenosine monophosphonate derivatives. Purinergic Signal. 2020;16:61\u201372. https:\/\/doi.org\/10.1007\/s11302-020-09688-0.","journal-title":"Purinergic Signal"},{"issue":"3","key":"3575_CR14","doi-asserted-by":"publisher","first-page":"902","DOI":"10.1021\/jm301372c","volume":"14","author":"TS Kumar","year":"2013","unstructured":"Kumar TS, Yang TH, Mishra S, Cronin C, Chakraborty S, Shen JB, Liang BT, Jacobson KA. 5\u2019-Phosphate and 5\u2019-Phosphonate Ester Derivatives of (N)-Methanocarba Adenosine with in Vivo Cardioprotective Activity. J Med Chem. 2013;14(3):902\u201314. https:\/\/doi.org\/10.1021\/jm301372c.","journal-title":"J Med Chem"},{"key":"3575_CR15","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1161\/01.RES.83.10.969","volume":"83","author":"FA Recchia","year":"1998","unstructured":"Recchia FA, McConnell PI, Bernstein RD, Vogel TR, Xu X, Hintze TH. Reduced nitric-oxide production and altered myocardial metabolism during the decompensation of pacing-induced heart failure in the conscious dog. Circ Res. 1998;83:969\u201379. https:\/\/doi.org\/10.1161\/01.RES.83.10.969. https:\/\/www.ahajournals.org\/doi\/epub\/.","journal-title":"Circ Res"},{"key":"3575_CR16","doi-asserted-by":"publisher","unstructured":"Qanud K, Mamdani M, Pepe M, Khairallah RJ, Gravel J, Lei B, Gupte SA, Sharov VG, Sabbah HN, Stanley WC, Recchia FA. Reverse changes in cardiac substrate oxidation in dogs recovering from heart failure. Am J Physiol. 2008;H2098\u20132105. https:\/\/doi.org\/10.1152\/ajpheart.00471.2008.","DOI":"10.1152\/ajpheart.00471.2008"}],"container-title":["Medicinal Chemistry Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00044-026-03575-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00044-026-03575-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00044-026-03575-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T04:42:32Z","timestamp":1792039352000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00044-026-03575-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,21]]},"references-count":16,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["3575"],"URL":"https:\/\/doi.org\/10.1007\/s00044-026-03575-w","relation":{},"ISSN":["1054-2523","1554-8120"],"issn-type":[{"value":"1054-2523","type":"print"},{"value":"1554-8120","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,21]]},"assertion":[{"value":"2 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"BTL is a consultant with a financial interest in Provascor Pharma, Inc, a University of Connecticut spinoff.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}}]}}